Table 1 Demographic characteristics and diagnoses of participants as provided at baseline

From: Insights into endometriosis symptom trajectories and assessment of surgical intervention outcomes using longitudinal actigraphy

Cohort demographics and characteristics

 

Variable

n (%) or Mean ± SD

Age

33.7 ± 7.4

Smoker

11 (16.2%)

Night shift work

2 (2.9%)

Nulliparous

46 (67.6%)

Duration of pelvic pain in months (n = 67)

155.3 ± 96.7

Analgesia taken regularly

41 (60.3%)

Opiates

18 (26.5%)

Analgesia taken for pelvic pain flares

60 (88.2%)

Opiates

36 (52.9%)

BMI

27.9 ± 6.4

Underweight (BMI \(< 18.5\))

1 (1.5%)

Normal (\(18.5\le\)BMI \(< 25\))

29 (42.6%)

Overweight (\(25\le\)BMI \(< 30\))

13 (19.1%)

Obese (\(30\le\)BMI \(< 40\))

23 (33.8%)

Severely obese (BMI \(\ge 40\))

2 (2.9%)

Ethnicity

White

64 (94.1%)

Asia/Asian British

1 (1.5%)

Black/African/Caribbean/Black British

0 (0%)

Multiple ethnic groups

1 (1.5%)

Other ethnic groups

2 (2.9%)

Education (highest achieved)

Primary

0 (0%)

Secondary

18 (26.5%)

Tertiary

50 (73.5%)

Endometriosis subtype

Superficial peritoneal

38 (55.9%)

Deep

38 (55.9%)

Ovarian

23 (33.8%)

Hormonal medication taken

42 (61.8%)

GnRH agonist taken – with HRT

12 (17.6%)

GnRH agonist taken – without HRT

3 (4.4%)

Combined oral contraceptive pill (COCP)

4 (5.9%)

Levonorgestrel intrauterine system (IUS)

18 (26.5%)

Progesterone only pill (POP)

6 (8.8%)

Nexplanon

3 (4.4%)

Depo-provera

1 (1.5%)

Comorbidities

Fibromyalgia

6 (8.8%)

Rheumatoid arthritis

1 (1.5%)

Irritable bowel syndrome (IBS)

10 (14.7%)

Autosomal dominant polycystic kidney disease (ADPKD)

0 (0%)

Migraine

27 (39.7%)

Other arthritis

3 (4.4%)

Chronic fatigue syndrome (CFS)

4 (5.9%)

Pancreatitis

0 (0%)

Painful bladder syndrome/interstitial cystitis

5 (7.5%)

Other chronic pain

12 (17.6%)

Gynecological history

Adenomyosis

9 (13.2%)

Heavy bleeding

29 (42.6%)

Fibroids

8 (11.8%)

Previous pelvic inflammatory disease (PID)

7 (10.3%)

Previous surgical treatment to endometriosis

45 (66.2%)

Previous hysterectomy

1 (1.5%)

Previous bilateral salpingo-oophorectomy

1 (1.5%)

  1. Entries are summarized in the form mean ± standard deviation, otherwise indicating the percentage within the cohort (when using parenthesis).